Transcat, Inc.
$92.97-$4.56 (-4.7%)
Last close · Data as of Nov 20, 2026
- Market cap
- $870.9M
- P/E
- 161.9x
- EV / EBITDA
- 25.8x
- Revenue
- $331.9M
- Net margin
- 1.6%
- ROCE
- 3.1%
Price chart
Technical chartScreen technicals →+72.9% over the last year
Daily closes.
Go deeper
Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes
Performance
Price return, before dividends, to the 20 Nov 2026 close.
- 1M
- +13.8%
- 3M
- +1.6%
- 6M
- +37.0%
- 1Y
- +72.9%
- 5Y
- -3.3%
52-week range
Day change -$4.56 (-4.7%) from $98 to $93 · Last close Nov 20, 2026
Best weekday to invest, historically
The same weekly amount in TRNS, bought on each weekday since 2021.
News & filings
What Transcat filed, who traded, and what's next
How to read this
"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.
AI Summary
US StockConcernThe P/E of 161.9 is more than four times the peer median of 13.5.
Strengths (1)
- Free cash flow was 3.64 times net profit in fiscal 2026.
Prices to the 20 Nov 2026 close · Financial year: fiscal 2026
Rule-based from financial data. Not advice.
About the company
Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Read moreShow less
Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control, and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value-added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense, industrial manufacturing, energy and utilities, chemical manufacturing, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.
- Sector
- Industrials
- Shares outstanding
- 9.3M
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- $870.9M
- P/E
- 161.9x
- P/B
- 2.9x
- EV / EBITDA
- 25.8x
- EV / Sales
- 3.0x
- P/S
- 2.6x
- 52-week high
- $109.56
- 52-week low
- $52.06
Profitability
- Operating margin
- 4.0%
- Net margin
- 1.6%
- EBITDA margin
- 11.7%
- ROE
- 1.8%
- ROCE
- 3.1%
- ROIC
- 4.4%
- ROA
- 1.1%
- Asset turnover
- 0.69
Growth
- RevenueFY2026, the latest fiscal year in the company's growth history.
- $331.9M
- Revenue growth, 1YFY2026, the latest fiscal year in the company's growth history.
- 19.2%
- Revenue CAGR, 3YFY2026, the latest fiscal year in the company's growth history.
- 12.9%
- Net profit growth, 1YFY2026, the latest fiscal year in the company's growth history.
- -63.0%
- Free cash flowFY2026, the latest fiscal year in the company's growth history.
- $19.6M
Solvency
- Current ratio
- 2.33
- Debt / Equity
- 0.44
- Debt / Assets
- 0.28
- CFO / Net profit
- 6.48
- Cash / Market cap
- 0.6%
Where the revenue went
Of every $100 of FY2026 revenue, $2 was left as net income.
| From | To | Amount |
|---|---|---|
| Revenue | Cost of revenue | $223.6M |
| Revenue | Gross profit | $108.3M |
| Gross profit | Selling, general and administrative | $95.0M |
| Gross profit | Other operating expenses | $10.0k |
| Gross profit | Operating income | $13.3M |
| Operating income | Pretax income | $8.0M |
| Operating income | Interest and other expense | $5.3M |
| Pretax income | Tax and other | $2.6M |
| Pretax income | Net income | $5.4M |
Revenue and net profit
Revenue grew 19.2% in FY2026; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2023 | $230.6M | $10.7M |
| FY2024 | $259.5M | $13.6M |
| FY2025 | $278.4M | $14.5M |
| FY2026 | $331.9M | $5.4M |
Cash flows
FY2026: $34.9M from operations, $19.6M free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2023 | $17.0M | $7.5M |
| FY2024 | $32.6M | $19.3M |
| FY2025 | $39.0M | $25.8M |
| FY2026 | $34.9M | $19.6M |
Growth
Latest fiscal year 2026: each figure with its change over the year before.
- Revenue
- $331.9M+19.2%1Y
- EBITDA
- $38.8M+2.8%1Y
- Net profit
- $5.4M-63.0%1Y
- Cash from operations
- $34.9M-10.6%1Y
- Free cash flow
- $19.6M-24.2%1Y
- Revenue CAGR, 3Y
- 12.9%
- Net profit CAGR, 3Y
- -20.5%
| Year | Revenue | EBITDA | Net profit | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|
| FY2026 | $331.9M | $38.8M | $5.4M | $19.6M | 1.8% | +19.2% | -63.0% |
Monthly returns
Month-by-month returns of TRNS across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2026.
| Line | FY2026 |
|---|---|
| Assets | $480.5M |
| Current assets | $92.5M |
| Non-current assets | $388.0M |
| Liabilities | $179.9M |
| Current liabilities | $39.6M |
| Non-current liabilities | $140.2M |
| Equity | $300.6M |
| Paid-in capital | $199.1M |
| Retained earnings | $97.8M |
Market cap against peers
8 peers: same sector, nearest by size.
Peers map
Industrials companies placed by value, growth and quality; TRNS highlighted.
P/E against peers
TRNS trades at 161.9x earnings against a peer median of 13.5x (a 1099% premium).
Not shown (no positive earnings and no EV / Sales): Mayville Engineering Company, Inc., Quanex Building Products Corporation.
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| Transcat, Inc.TRNSthis companyP/E ↑ premium | $870.9M | 161.9x | 2.9x | 1.8% | 25.8x |
| National Presto Industries, Inc.NPK | $939.0M | 28.4x | 2.4x | 8.4% | 20.2x |
| Power Solutions International, Inc.PSIX | $926.2M | 8.1x | 5.2x | 63.8% | 9.0x |
| CRA International, Inc.CRAI | $921.5M | 16.9x | 4.3x | 25.6% | 9.2x |
| Sun Country Airlines Holdings, Inc.SNCY | $876.4M | 16.6x | 1.4x | 8.4% | 6.4x |
| Kforce Inc.KFRC | $857.0M | 24.6x | 6.9x | 27.9% | 16.9x |
| Mayville Engineering Company, Inc.MEC | $833.1M | -102.7x | 3.5x | -3.4% | 28.5x |
| Quanex Building Products CorporationNX | $818.2M | -3.3x | 1.1x | -34.5% | -19.1x |
| Cryoport, Inc.CYRX | $814.5M | 10.4x | 1.8x | 17.0% | -379.0x |
| Peer median | — | 13.5x | 2.9x | 12.7% | 9.1x |
Year-to-date ROI
TRNS since 1 January, against earlier years.
Historical volatility
TRNS's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.
Consolidated figures in USD, fiscal years, newest first.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2023 | 7.0% |
| FY2024 | 7.6% |
| FY2025 | 6.4% |
| FY2026 | 4.0% |
| Line | FY2026 |
|---|---|
| RevenueTotal Revenue | $331.9M |
| Cost of revenueCost Of Revenue | $223.6M |
| Gross profitGross Profit | $108.3M |
| Operating expensesOperating Expense | $95.0M |
| Selling, general and administrativeSelling General And Administration | $95.0M |
| Total expensesTotal Expenses | $318.6M |
| Operating incomeOperating Income | $13.3M |
| Interest and other | |
| Pretax incomePretax Income | $8.0M |
| TaxTax Provision | $2.6M |
| Net incomeNet Income | $5.4M |
| Per share | |
| Supplementary |
| Line | FY2026 |
|---|---|
| AssetsTotal Assets | $480.5M |
| Current assetsCurrent Assets | $92.5M |
| Non-current assetsTotal Non Current Assets | $388.0M |
| LiabilitiesTotal Liabilities Net Minority Interest | $179.9M |
| Current liabilitiesCurrent Liabilities | $39.6M |
| Non-current liabilitiesTotal Non Current Liabilities Net Minority Interest | $140.2M |
| EquityTotal Equity Gross Minority Interest | $300.6M |
| Supplementary |
| Line | FY2026 |
|---|---|
| Operating cash flowOperating Cash Flow | $34.9M |
| Cash from continuing operationsCash Flow From Continuing Operating Activities | $34.9M |
| Net income, continuing operationsNet Income From Continuing Operations | $5.4M |
| Depreciation and amortisationDepreciation And Amortization | $26.2M |
| Depreciation, amortisation and depletionDepreciation Amortization Depletion | $26.2M |
| Stock-based compensationStock Based Compensation | $7.5M |
| Deferred taxDeferred Tax | $830.0k |
| Deferred income taxDeferred Income Tax | $830.0k |
| Operating gains and lossesOperating Gains Losses | $230.0k |
| Gain loss on sale of PP&EGain Loss On Sale Of PPE | $230.0k |
| Provision and write off of assetsProvisionand Write Offof Assets | $470.0k |
| Change in working capitalChange In Working Capital | -$11.9M |
| Other non-cash itemsOther Non Cash Items | $6.1M |
| Investing cash flowInvesting Cash Flow | -$97.8M |
| Cash from continuing investingCash Flow From Continuing Investing Activities | -$97.8M |
| Capital expenditureCapital Expenditure | -$15.3M |
| Purchase of PP&EPurchase Of PPE | -$15.3M |
| Sale of PP&ESale Of PPE | — |
| Net PP&E purchases and salesNet PPE Purchase And Sale | -$15.3M |
| AcquisitionsPurchase Of Business | -$82.5M |
| Net acquisitions and disposalsNet Business Purchase And Sale | -$82.5M |
| Purchase of investmentsPurchase Of Investment | — |
| Net investment purchases and salesNet Investment Purchase And Sale | $0.00 |
| Other investing changesNet Other Investing Changes | — |
| Financing cash flowFinancing Cash Flow | $66.5M |
| Cash from continuing financingCash Flow From Continuing Financing Activities | $66.5M |
| Debt issuedIssuance Of Debt | $156.7M |
| Debt repaidRepayment Of Debt | -$90.2M |
| Net debt issuedNet Issuance Payments Of Debt | $66.5M |
| Net short-term debt issuedNet Short Term Debt Issuance | — |
| Long-term debt issuedLong Term Debt Issuance | $156.7M |
| Long-term debt repaidLong Term Debt Payments | -$90.2M |
| Net long-term debt issuedNet Long Term Debt Issuance | $66.5M |
| Shares issuedIssuance Of Capital Stock | $840.0k |
| Common stock issuedCommon Stock Issuance | $840.0k |
| Net common stock issuedNet Common Stock Issuance | $370.0k |
| Common stock repurchasedCommon Stock Payments | -$470.0k |
| Share buybacksRepurchase Of Capital Stock | -$470.0k |
| Other financing chargesNet Other Financing Charges | -$360.0k |
| Change in cashChanges In Cash | $3.5M |
| Effect of exchange ratesEffect Of Exchange Rate Changes | -10.0% |
| Cash at the start of the yearBeginning Cash Position | $1.5M |
| Cash at the end of the yearEnd Cash Position | $4.9M |
| Free cash flowFree Cash Flow | $19.6M |
| Supplemental |
Learn while you research
Academy chapters picked for Transcat, Inc. and the metrics on this page.
- 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 02 Valuation Multiples ExplainedThis stock trades at a P/E of 161.9, learn when high multiples are justified.6 min read
- 03 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
- 04 Business Cycles & StocksThese cyclical sectors win and lose in different macro phases.6 min read
- 05 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
- 06 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read